Webinar: Partnering with ACD’s Professional Assay Services to Decode the Tumor Microenvironment with RNAscope™ ISH Assays

The field of immuno-oncology is rapidly advancing, requiring specialized tools to understand both target expression and interaction within the tumor microenvironment. Tumors are intricate structures composed of various cell types, including malignant cells, immune cells, endothelial cells, and fibroblasts, which dynamically interact within this complex environment.

In this webinar, Bio-Techne’s PAS team will demonstrate how RNAscope multiomics spatial technology provides unparalleled insight into immune cell localization, biomarker expression, and therapeutic responses. Additionally, we will discuss how we support emerging therapeutic approaches such as Antibody Drug Conjugates (ADCs) and bispecific antibodies, including T-cell engagers. By leveraging RNAscope technology, researchers can effectively navigate the complexities of tumor biology and translate their discoveries into impactful clinical strategies.

Join us to learn how partnering with PAS can propel your immuno-oncology research from discovery to development.

Learning Objectives:

• Detect and localize RNA and protein tumor biomarkers
• Evaluate spatial heterogeneity of tumors
• Characterize the immune landscape of tumors
• Investigating spatial interactions between cancer cells and immune cells

Explore how RNAscope technology can enable next-generation immuno-oncology therapies.

Presenter:
Harry Liu
Research Associate, Professional Assay Services (PAS) Team